1、To confirm the renal protective action of Astragalus Angelica mixture.
為探討黃芪當(dāng)歸合劑降脂的腎臟保護(hù)作用。

2、Astragalus polysaccharide is one of the main high active components of Astragalus.
黃芪多糖是黃芪的主要活性成分之一。

3、Objective: To observe the effect of Astragalus and Angelica extract on mice model of WBC.
目的：觀察黃芪和當(dāng)歸不同配伍提取物對(duì)造模小鼠白細(xì)胞的影響。

4、This paper deals with the demarcation between Astragalus and Chesneya.
本文討論了黃芪屬與雀兒豆屬的定界問(wèn)題。

5、Result: the immunoregulation effect of the astragalus was various.
結(jié)果：黃芪的免疫調(diào)節(jié)作用是多方面的。

6、After injecting astragalus in the points, prepared model by hypodermic injection of scopolamine.
穴位注射黃芪注射液后，皮 * 射東莨菪堿造模。

7、Objective: To investigate the immunomodulatory effects of total astragalus extract.
目的：研究黃芪總提物（TAE）的免疫調(diào)節(jié)作用。

8、Objective: To establish the optimum method of purifying astragalus in compound Qishe Tablets.
前言：目的：確定復(fù)方芪麝片中黃芪等藥味的最佳純化工藝。

9、Conclusion Ultrasonic disrupter is suitable to extract Astragalus polysaccharides.
結(jié)論超聲細(xì)胞粉碎儀適宜黃芪多糖的提取。

10、Objective To observe the influence of different doses of astragalus in cats.
目的觀察不同劑量的黃芪對(duì)貓正常血壓的影響。

11、Objective: To investigate the effect of Astragalus extract on acute heart failure in dogs.
目的：考察黃芪提取物對(duì)犬心力衰竭模型的作用。

12、The rate of leukopenia in astragalus group was significantly lower than those in control group (P
黃芪組的白細(xì)胞減少發(fā)生率顯著低于對(duì)照組（P

13、Objective: To investigate the efficacy of Astragalus Injection on diabetic nephrosis.
目的：觀察黃芪注射液治療糖尿病腎病的療效。

14、Diseases of Astragalus adsurgens in Neimenggu and Western Liaoning
內(nèi)蒙古及遼寧西部沙打旺的病害

15、Conclusion: The astragalus plays role in immunological improvement and bidirectional regulation.
結(jié)論：黃芪有明顯的免疫促進(jìn)、向調(diào)節(jié)作用。

16、Studying acute toxicity and maximum tolerable dose of Astragalus composition F3 new preparation.
研究黃芪成分f 3新制劑的急性毒性和最大耐受量。

astragalus翻譯